Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.69 |
| ▸ | GSR | P00390 | 2/20 | 0.53 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.47 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.47 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.45 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.43 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.43 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.43 |
| ▸ | GRM8 | O00222 | 1/20 | 0.43 |
| ▸ | GRM6 | O15303 | 1/20 | 0.43 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.43 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRM5 | P41594 | 1/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30026189 | 1.00 | FOLH1 (0.69) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL1973946 | 1.00 | FOLH1 (0.69) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL14413853 | 1.00 | FOLH1 (0.69) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL31344444 | 1.00 | FOLH1 (0.69) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL30984646 | 1.00 | FOLH1 (0.69) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL29630778 | 0.97 | FOLH1 (0.66) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL7166207 | 0.96 | FOLH1 (0.68) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL31635790 | 0.96 | FOLH1 (0.68) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL31635787 | 0.96 | FOLH1 (0.68) | FOLH1GSRRIMKLANAALAD2DPP8 | |
| SCHEMBL31635789 | 0.96 | FOLH1 (0.68) | FOLH1GSRRIMKLANAALAD2DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367332-A1 | PSMA-TARGETED RADIOACTIVE METAL COMPLEX CONTAINING NITROAROMATIC HETEROCYCLIC GROUP AND PREPARATION METHOD | UNIV BEIJING NORMAL (CN) | 2025-12-04 | — | — | US | claimed |
| US-12377110-B2 | Fospropofol methods and compositions | EPALEX CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| WO-2025067293-A1 | HELICASE AND USE THEREOF | 北京齐碳科技有限公司 | 2025-04-03 | — | — | WO | claimed |
| WO-2025067393-A1 | DISACCHARIDE-ACYLHYDRAZONE OR DISACCHARIDE-HYDRAZIDE LINKER, GLYCO-ENGINEERED ANTIBODY AND SUGAR-CHAIN SITE-DIRECTED ANTIBODY-DRUG CONJUGATE BASED ON SAME, AND USE THEREOF | 上海糖岭生物医药有限责任公司 | 2025-04-03 | — | — | WO | claimed |
| CN-119708088-A | Disaccharide-acylhydrazone or disaccharide-hydrazide linker, sugar engineering antibody based on same, sugar chain fixed-point antibody-drug conjugate and application | 上海糖岭生物医药有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119709689-A | Helicase and application thereof | 北京齐碳科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-115353546-B | Preparation and application of oligopeptide modified bisindolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2024-10-08 | — | — | CN | claimed |
| CN-118000360-A | Feed additive for promoting fish growth and resisting ammonia nitrogen stress and feed | 长沙学院 | 2024-05-10 | — | — | CN | claimed |
| CN-117858890-A | Polypeptide compound and application thereof in treating enteritis | 四川好医生攀西药业有限责任公司 | 2024-04-09 | — | — | CN | claimed |
| CN-115068624-B | Peptide dendrimer drug-carrying system and preparation method and application thereof | 重庆理工大学 | 2024-02-13 | — | — | CN | claimed |
| WO-2023088140-A1 | STAPLED PEPTIDE AND USE THEREOF | 南京明德新药研发有限公司 | 2023-05-25 | — | — | WO | claimed |
| US-20230084521-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2023-03-16 | — | — | US | claimed |
| US-20220401592-A1 | LOW MOLECULAR WEIGHT AND POLYAMIDOAMINE (PAMAM) DENDRIMER BASED PSMA-SPECIFIC DUAL CONTRAST AGENTS FOR OPTICAL AND PHOTOACOUSTIC IMAGING AND THERANOSTIC AGENTS FOR TREATING PROSTATE CANCER | THE JOHNS HOPKINS UNIVERSTY | 2022-12-22 | — | — | US | claimed |
| CN-115353546-A | Preparation and application of oligopeptide-modified bis-indolylethyl-beta-carboline-3-carboxylic acid | 首都医科大学 | 2022-11-18 | — | — | CN | claimed |
| WO-2022207818-A1 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING POST COVID-19 | PANTAPHARM AG (DE) | 2022-10-06 | — | — | WO | claimed |
| CN-115068624-A | Peptide dendrimer drug-carrying system and preparation method and application thereof | 重庆理工大学 | 2022-09-20 | — | — | CN | claimed |
| US-20220105050-A1 | PROPOFOL PRODRUG METHODS AND COMPOSITIONS | EPALEX CORPORATION | 2022-04-07 | — | — | US | claimed |
| CN-107739400-A | A kind of synthetic method of lysine dipeptides | 湖北泓肽生物科技有限公司 | 2018-02-27 | — | — | CN | claimed |
| EP-1089753-B1 | USE OF A DIPEPTIDE FOR STIMULATING REPAIR PROCESSES | OBSCHESTVO S OGRANICHENNOI OTV (RU) | 2003-07-23 | — | — | EP | claimed |
| WO-2002062371-A1 | DIPEPTIDE INHIBITING ANGIOGENESIS IN OPHTHALMOPATHOLOGY | SANKT-PETERBURGSKAYA OBSCHESTVENNAYA ORGANIZATSIA 'SANKT-PETERBURGSKIY INSTITUT BIOREGULYATSII I GERONTOLOGII SZO RAMN' (RU) | 2002-08-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250367332-A1 | PSMA-TARGETED RADIOACTIVE METAL COMPLEX CONTAINING NITROAROMATIC HETEROCYCLIC GROUP AND PREPARATION METHOD | PSMA1, PSMA2, PSMA7 | FOLH1 6/4885GSR 2407/4885RIMKLA 723/4885 |
| US-12377110-B2 | Fospropofol methods and compositions | FOS, FOSB, PFAS | FOLH1 387/4885GSR 4624/4885RIMKLA 1929/4885 |
| US-20220401592-A1 | LOW MOLECULAR WEIGHT AND POLYAMIDOAMINE (PAMAM) DENDRIMER BASED PSMA-SPECIFIC DUAL CONTRAST AGENTS FOR OPTICAL AND PHOTOACOUSTIC IMAGING AND THERANOSTIC AGENTS FOR TREATING PROSTATE CANCER | PAM, FOLH1, KLK3 | FOLH1 2/4885GSR 3435/4885RIMKLA 1188/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.